ACLY and systemic lupus erythematosus: aPL are a heterogeneous group of autoantibodies, such as anticardiolipin antibodies (aCL), lupus anticoagulant (LA) and anti-β2-glycoprotein-I (anti-β2GPI), that are frequently observed in autoimmune disorders, especially in SLE.